Table 1.
Non-invasive neuromodulation | Strengths | Weaknesses |
---|---|---|
Repetitive transcranial magnetic stimulation (rTMS) Electromagnetic coil is used to modulate cortical excitability in a target brain region, e.g. DLPFC |
• Minimal adverse effects • Safe and well-tolerated in EDs • Evidence for benefits in BMI, ED and mood symptoms in SE-AN • Evidence for cognitive benefits across EDs |
• Time-intensive, 20–30 sessions for optimal effects • Heterogeneity in response • Optimal parameters yet to be determined • Small evidence base in BED and BN • Cost-effectiveness yet to be determined |
Transcranial direct current stimulation (tDCS) Applies weak direct current to the scalp to modulate existing neuronal activity |
• Ease of use and minimal adverse effects • Safe and well-tolerated in EDs • Can be used “online” and applied at-home • Evidence for short-term benefits in cognition and ED symptoms • Low-cost treatment |
• Few studies have applied tDCS therapeutically (i.e. > 5 sessions) • Lack of RCTs across EDs |
Transcutaneous auricular vagus nerve stimulation (taVNS) Attached to the auricular concha and delivers electrical stimulation at the subcutaneous course of the vagus nerve |
• Non-invasive alternative to surgical VNS • Can be delivered at-home • Low-cost treatment |
• Small evidence base in psychiatric disorders, with only one case series in EDs |
Electroconvulsive therapy (ECT) Performed under general anaesthesia using electrical stimulation to the scalp to induce a generalised tonic–clonic seizure |
• May have positive effects on comorbid mood symptoms •Effect on weight unclear “last resort” treatment option |
• Adverse effects, e.g. cognition and memory • Not a long-term treatment option • No RCTs to show clinical efficacy in AN • Not associated with improvement in ED symptoms |
Invasive neuromodulation | ||
Deep brain stimulation (DBS) Electrical impulses are delivered to illness-relevant brain regions via implanted electrodes |
• Preliminary success for improving BMI, ED and affective symptoms in SE-AN • Relatively safe in the short- and long-term • Focal stimulation • Targets subcortical regions that are inaccessible with other neuromodulation techniques |
• Adverse side effects (e.g. infection) may be over-represented in SE-AN • Requires neurosurgery • Close monitoring or follow-up is essential which patients may find burdensome • Switching the device off could lead to deterioration of symptoms (i.e. not reversible) • Expensive treatment |